You have 9 free searches left this month | for more free features.

Dabrafenib

Showing 151 - 171 of 171

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced or Metastatic Melanoma, Advanced or Metastatic NSCLC Trial in France (immune-checkpoint inhibitors therapies)

Unknown status
  • Advanced or Metastatic Melanoma
  • Advanced or Metastatic NSCLC
  • immune-checkpoint inhibitors therapies
  • Marseille, Bouches Du Rhône, France
  • +8 more
Sep 25, 2019

Melanoma, Malignant, of Soft Parts Trial in Netherlands (Vemurafenib and Cobimetinib)

Recruiting
  • Melanoma, Malignant, of Soft Parts
  • Vemurafenib and Cobimetinib
  • Amsterdam, Netherlands
  • +12 more
Jun 3, 2020

Metastatic Cancer Trial in Hangzhou (Non Chemotherapy, Chemotherapy and target therapy, Chinese herb medicine)

Unknown status
  • Metastatic Cancer
  • Non Chemotherapy
  • +2 more
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital, affiliated with Zhejiang University S
Feb 12, 2019

Unresectable Stage III and Metastatic Melanoma in United States

Completed
  • Melanoma
  • Non-Interventional
  • Morristown, New Jersey
    Local Institution
Feb 5, 2018

Melanoma Trial in France (Trametinib, Dabrafenib)

No longer available
  • Melanoma
  • Amiens Cedex, France
  • +45 more
Aug 9, 2017

Cancer Trial in Australia, United States (GSK2118436, Midazolam)

Completed
  • Cancer
  • Los Angeles, California
  • +7 more
Nov 8, 2017

Cancer Trial in Tacoma (GSK2118436)

Completed
  • Cancer
  • Tacoma, Washington
    GSK Investigational Site
Nov 8, 2017

Cancer Trial in Tacoma (GSK2118436)

Completed
  • Cancer
  • Tacoma, Washington
    GSK Investigational Site
Nov 8, 2017

Cancer Trial in Shizuoka, Tokyo (GSK2118436)

Completed
  • Cancer
  • Shizuoka, Japan
  • +1 more
Nov 8, 2017

Metastatic Melanoma Trial (Nivolumab, Trametinib, Dabrafenib)

Withdrawn
  • Metastatic Melanoma
  • (no location specified)
Dec 9, 2015

Melanoma Trial in Worldwide (GSK2118436)

Completed
  • Melanoma
  • Los Angeles, California
  • +22 more
Aug 29, 2017

Melanoma Trial in Houston (GSK2118436, GSK1120212)

Completed
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 19, 2016

Cancer Trial in Australia, United Kingdom, United States (GSK2118436 75 mg, Placebo)

Completed
  • Cancer
  • GSK2118436 75 mg
  • Placebo
  • Scottsdale, Arizona
  • +7 more
Nov 8, 2017

Cancer Trial in Worldwide (GSK2118436, Dacarbazine (DTIC))

Completed
  • Cancer
  • Birmingham, Alabama
  • +93 more
Sep 6, 2017

After Vemurafenib / BRAF Inhibitors Interruption in

Unknown status
  • Erdheim-Chester Disease
    • New York, New York
    • +1 more
    Oct 27, 2016

    Melanoma (Skin) Trial in Amiens (Development of the most specific physiologically relevant experimental patient models)

    Unknown status
    • Melanoma (Skin)
    • Development of the most specific physiologically relevant experimental patient models
    • Amiens, Picardie, France
      CHU Amiens Picardie
    Apr 28, 2017

    Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)

    Completed
    • Atrial Fibrillation
    • São Paulo, Brazil
      Hospital São Paulo/Hospital Universitário da UNIFESP (University
    Nov 21, 2016

    Local Metastatic Melanoma Trial in France (DT01)

    Completed
    • Local Metastatic Melanoma
    • Bordeaux, France
    • +11 more
    Jun 16, 2016

    Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (Akt inhibitor MK2206, selumetinib,

    Terminated
    • Recurrent Melanoma
    • +4 more
    • Akt inhibitor MK2206
    • +2 more
    • Atlanta, Georgia
    • +3 more
    May 16, 2014

    Melanoma and Brain Metastases Trial in Worldwide (GSK2118436)

    Completed
    • Melanoma and Brain Metastases
    • Los Angeles, California
    • +23 more
    Apr 24, 2014